Nurix Therapeutics, Inc. (NRIX)

NASDAQ: NRIX · Real-Time Price · USD

15.64

+1.00 (6.83%)

At close: Jun 8, 2026, 4:00 PM EDT

15.40

-0.24 (-1.53%)

After-hours: Jun 8, 2026, 5:02 PM EDT

Nurix Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is December - November.

Millions USD. Fiscal year is Dec - Nov.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 8, 2026	Nov '25 Nov 30, 2025	Nov '24 Nov 30, 2024	Nov '23 Nov 30, 2023	Nov '22 Nov 30, 2022	Nov '21 Nov 30, 2021
Market Cap	1,617	1,800	1,678	303	584	1,287
Market Cap Growth	116.91%	7.30%	453.58%	-48.15%	-54.60%	-22.29%
Enterprise Value	1,124	1,260	1,088	38.25	281.76	1,001
Last Close Price	15.64	17.68	22.11	6.22	12.39	28.82
PS Ratio	22.37	21.43	30.75	3.94	15.13	43.27
PB Ratio	3.15	3.34	3.18	1.51	1.92	3.76
P/TBV Ratio	3.03	2.84	2.82	1.69	1.98	3.61
EV/Sales Ratio	15.66	15.00	19.95	0.50	7.29	33.64
Debt / Equity Ratio	0.12	0.10	0.04	0.12	0.02	0.03
Net Debt / Equity Ratio	-1.00	-1.00	-1.10	-1.28	-0.98	-0.83
Net Debt / EBITDA Ratio	1.58	2.01	2.96	1.82	1.72	2.53
Net Debt / FCF Ratio	3.82	2.04	3.19	2.88	1.73	3.14
Asset Turnover	0.11	0.12	0.11	0.20	0.09	0.07
Quick Ratio	5.86	6.86	6.36	3.31	4.38	4.56
Current Ratio	6.01	7.02	6.46	3.40	4.51	4.70
Return on Equity (ROE)	-40.82%	-49.63%	-53.22%	-57.10%	-55.84%	-37.05%
Return on Assets (ROA)	-47.79%	-42.21%	-41.63%	-40.15%	-41.16%	-27.03%
Return on Invested Capital (ROIC)	-308.12%	-289.30%	-201.23%	-120.60%	-104.41%	-69.13%
Return on Capital Employed (ROCE)	-55.05%	-48.62%	-50.59%	-50.45%	-48.60%	-30.93%
Buyback Yield / Dilution	-25.59%	-29.12%	-23.52%	-11.79%	-13.32%	-173.68%
Total Shareholder Return	-25.59%	-29.12%	-23.52%	-11.79%	-13.32%	-173.68%

SEC Filings: 10-K · 10-Q